• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Capstone Publishes Investor FAQ Detailing Margin Expansion, Operating Leverage, and Capital Discipline

    1/28/26 8:00:00 AM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CAPS alert in real time by email

    Management outlines progress converting platform scale into profitability while reducing long-term dilution risk.

    NEW YORK CITY, NEW YORK / ACCESS Newswire / January 28, 2026 / Capstone Holding Corp. (NASDAQ:CAPS), a national building products distribution platform, today published an investor FAQ detailing management's strategy to convert platform scale into margin expansion, cash generation, and long-term per-share value creation.

    The FAQ provides additional clarity on the Company's capital allocation, with growth initiatives increasingly supported by operating leverage and senior credit to reduce long-term dilution risk.

    "We value the engagement of our shareholders and take their feedback seriously," said Matthew Lipman, Chief Executive Officer of Capstone. "This FAQ is intended to help the market better understand our next phase, which is focused on achieving profitability through disciplined execution. With operating leverage and cash generation improving, we believe Capstone is on a strong trajectory."

    Key Highlights:

    • Reduced Reliance on Equity Financing: With operating leverage and cash generation improving, Capstone expects an increasing share of growth initiatives to be funded through operating cash flow and senior credit rather than equity issuance.

    • Defined Path to Profitability: Management targets a positive corporate EBITDA run-rate beginning in Q2 2026, supported by operating leverage, high-margin products and services, purchasing power, and sustained cost discipline.

    • Strategy-Aligned Capital Structure: Capstone's capital structure is designed to remain flexible as cash flow scales-supporting extensions, refinancing, or consolidation into longer-dated senior facilities. Management does not view debt maturities as a constraint on operations or growth.

    • Disciplined, Accretive Growth Model: Capstone continues to pursue selective acquisitions that enhance route density, margin mix, and operating leverage. Acquisitions are evaluated for immediate accretion, strategic fit, and per-share value creation.

    • Financial Outlook on Track: Capstone continues to pursue a $100 million revenue run-rate and steady progress towards 10% EBITDA margins as the business transitions from platform expansion to monetizing scale.

    Margin Expansion Underway

    Following the successful integration of Canadian Stone Industries (CSI) and prior acquisitions, Capstone is focused on converting platform scale into margin expansion. The Instone operating platform is delivering measurable efficiencies across inventory management, logistics, and sales coverage, allowing incremental revenue to translate more directly into EBITDA. As revenue grows beyond Capstone's current $70 million run-rate, management expects a larger share of growth to flow to the bottom line.

    Recent actions, including a $2.0 million cost rationalization, are already accelerating the Company's path toward positive EBITDA. Capstone expects to announce additional operational initiatives in the coming weeks aimed at further improving margins.

    Capital structure management is a central component of this strategy. Capstone is completing an inventory valuation expected to increase advance rates under its borrowing base, expanding available liquidity. In the interim, Instone's revolver remains fully supported, penalty-free, and appropriately sized for working-capital needs, with no near-term refinancing pressure.

    Additional information is available in the Company's Form 8-K. Management expects to release an earnings power presentation in Q1 2026 which will provide further detail on the Company's performance.

    About Capstone Holding Corp.

    Capstone Holding Corp. (NASDAQ:CAPS) is a national, technology-enabled building products distribution platform optimizing supply chains across 38 U.S. states and Canada. Through its Instone operating platform and inventory portal, the Company aggregates and delivers proprietary stone veneer, hardscape materials, and modular masonry systems. Capstone's model combines digital infrastructure, owned-inventory logistics, and disciplined acquisitions to drive scalable margin expansion and operating leverage across its growing platform.

    Investor Contact

    Investor Relations
    Capstone Holding Corp.
    [email protected]
    www.capstoneholdingcorp.com

    Forward-Looking Statements

    This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements relate to future events and performance, including guidance regarding revenue and EBITDA targets, M&A strategy, use of capital, and operating outlook. Actual results may differ materially from those projected due to a range of factors, including but not limited to acquisition timing, macroeconomic conditions, and execution risks. Please review the Company's filings with the SEC for a full discussion of risk factors. Capstone undertakes no obligation to revise forward-looking statements except as required by law.

    SOURCE: Capstone Holding Corp.



    View the original press release on ACCESS Newswire

    Get the next $CAPS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CAPS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CAPS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Schultz Edward Christopher

    4 - Capstone Holding Corp. (0000887151) (Issuer)

    4/1/26 6:42:32 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Lipman Matthew E.

    4 - Capstone Holding Corp. (0000887151) (Issuer)

    4/1/26 6:41:21 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Toporek Michael

    4 - Capstone Holding Corp. (0000887151) (Issuer)

    4/1/26 6:40:16 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CAPS
    SEC Filings

    View All

    Amendment: SEC Form 10-K/A filed by Capstone Holding Corp.

    10-K/A - Capstone Holding Corp. (0000887151) (Filer)

    4/17/26 5:15:36 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form 10-K/A filed by Capstone Holding Corp.

    10-K/A - Capstone Holding Corp. (0000887151) (Filer)

    4/17/26 4:10:39 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Capstone Holding Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Capstone Holding Corp. (0000887151) (Filer)

    4/16/26 3:09:28 PM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CAPS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Capstone Announces Investor FAQ Focused on 2026 Guidance and Earnings

    Company invites shareholder submissions; FAQ to expand on growth trajectory, margin profile, and path to profitability Capstone Holding Corp. (NASDAQ:CAPS), a tech-enabled building products distribution platform, will publish an investor FAQ during the week of May 4, addressing key questions from its shareholder base. The FAQ will provide additional detail on the Company's recent earnings and 2026 guidance, which includes 54% revenue growth and approximately 4x EBITDA growth. Ahead of publication, Capstone is inviting shareholders to submit questions by emailing [email protected]. Submissions will be reviewed by the Company's leadership team, with a selection of response

    4/21/26 7:30:00 AM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Capstone Reports FY2025 Results and Guides to 54% Revenue Growth and 4x EBITDA Growth in 2026

    FY2025 gross margin expands to 23% on $46.9M revenue; FY2026 guidance calls for $72.1M of revenue, ~$18.7M of gross profit (+73%), and a positive EBITDA run-rate starting in Q2 Capstone Holding Corp. (NASDAQ:CAPS), a tech-enabled building products distribution platform, today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. The Company closed FY2025 with ~$46.9 million in revenue and gross margin expanding to 23.0%, reflecting acquisition-driven scale and a higher-margin product mix. For FY2026, Capstone expects revenue to rise 54% to $72.1 million, gross margin to reach 26%, and EBITDA to increase more than fourfold to approximatel

    4/16/26 7:30:00 AM ET
    $CAPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Capstone Awarded Eldorado Stone Distribution, Targeting $5 Million in Organic Revenue Growth

    $5 million in organic revenue sold through existing distribution channels with no incremental investment; share-of-wallet capture from existing customers accelerates near-term revenue ramp Capstone Holding Corp. (NASDAQ:CAPS), a tech-enabled building products distribution platform, today announced it has been awarded distribution rights for Eldorado Stone, a premium manufactured stone veneer brand from Westlake Royal Building Products. The Company expects the addition will contribute $5 million in annualized run-rate revenue by Q3 2027, sold entirely through Capstone's existing distribution channels with no incremental infrastructure investment. Capstone is already a top-three national

    4/6/26 7:30:00 AM ET
    $CAPS
    $WLK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Major Chemicals
    Industrials